However, some of our observed mutations have not been linked to dMMR CRCs yet (53, 55) and we could detect up to six synchronous MMR/HRR mutations in our MLH1-/PMS2-/MSH6- cases, which is something we rarely observe in clinical practice in other cancer entities. Here, PMS2 is linked to cancer.